ArticleJournal of cellular physiology2011

Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.

Mary E Irwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.